Literature DB >> 25260052

Transepidermal drug delivery: a new treatment option for areata alopecia?

Maria Claudia Almeida Issa1, Marianna Pires, Priscilla Silveira, Esther Xavier de Brito, Cristiane Sasajima.   

Abstract

BACKGROUND: Transepidermal drug delivery (TED) is a new potential method in dermatology. Permeability alterations induced by ablative fractional resurfacing have been described with the aim to increasing the delivery of different substances into the skin.
OBJECTIVE: To evaluate clinical response and side effects of TED in areata alopecia (AA) treatment using ablative fractional methods associated with acoustic pressure ultrasound (US) to deliver triamcinolone solution into the skin. METHODS AND MATERIALS: Five cases of AA underwent treatment which comprised of 3 steps: 1) Ablative fractioned RF or CO2 laser 2) topical application of triamcinolone 3) acoustic pressure wave US. The number of sessions varied according to the clinical response, ranging from one to six sessions.
RESULTS: All patients had complete recovery of the area treated. Two of them treated with ablative fractional RF + triamcinolone + US had complete response after three and six sessions. The other two treated with ablative fractional CO2 + triamcinolone + US had complete response after one session.
CONCLUSION: Fractioned ablative resurfacing associated with acoustic pressure wave US is a new option to areata alopecia treatment with good clinical result and low incidence of side effects.

Entities:  

Keywords:  CO2 laser; alopecia; radiofrequency; transdermal administration

Mesh:

Substances:

Year:  2014        PMID: 25260052     DOI: 10.3109/14764172.2014.967778

Source DB:  PubMed          Journal:  J Cosmet Laser Ther        ISSN: 1476-4172            Impact factor:   2.247


  4 in total

Review 1.  Efficacy of fractional lasers in treating alopecia: a literature review.

Authors:  Marina Perper; Adam S Aldahan; Rachel A Fayne; Christopher P Emerson; Keyvan Nouri
Journal:  Lasers Med Sci       Date:  2017-08-16       Impact factor: 3.161

2.  A randomized, investigator-blinded, controlled, split-scalp study of the efficacy and safety of a 1550-nm fractional erbium-glass laser, used in combination with topical 5% minoxidil versus 5% minoxidil alone, for the treatment of androgenetic alopecia.

Authors:  Poonkiat Suchonwanit; Salinee Rojhirunsakool; Saranya Khunkhet
Journal:  Lasers Med Sci       Date:  2019-04-13       Impact factor: 3.161

3.  Evaluation of fractional carbon dioxide laser alone versus its combination with betamethasone valerate in treatment of alopecia areata, a clinical and dermoscopic study.

Authors:  Dalia Abdel Halim; Mariam Nayer; Solwan Ibrahim El-Samanoudy; Heba Mohamed Abdel Raheem; Nanis Ragab
Journal:  Arch Dermatol Res       Date:  2022-09-17       Impact factor: 3.033

4.  Bimatoprost drug delivery with laser and microneedling for the management of COVID-19 prone positioning-induced atrophy and hypopigmentation.

Authors:  Britney N Wilson; Abdullah Aleisa; Christian Menzer; Anthony M Rossi
Journal:  JAAD Case Rep       Date:  2021-07-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.